Rhovica Neuroimaging secures CHF 2.3M financing to accelerate development of SoNav™ neurosurgical device
26.08.2025
Rhovica Neuroimaging AG, a Swiss MedTech startup, has raised CHF 2.3 million in a financing round led by M2care, with participation from Kickfund, Valuemaker and several other business angels. The funding will accelerate the development of SoNav, Rhovica's bedside navigation system for extraventricular drainage (EVD) catheters used in emergency neurosurgery.
 |
 |
Swiss MedTech startup Rhovica Neuroimaging has raised CHF 2.3 million (EUR 2.5 million) in a round led by M2care, with Kickfund, Valuemaker, and business angels participating. The funding will advance SoNav, Rhovica’s bedside navigation system for extraventricular drainage (EVD) catheters in emergency neurosurgery.
EVD catheters are often placed blindly to relieve intracranial pressure after trauma or bleeding, posing clinical risks. SoNav provides real-time bedside visualization and guidance to improve accuracy, speed, and monitoring in intensive care.
To support its growth, Rhovica has appointed Carsten Laue, Managing Director at M2care, to its Board of Directors. Investors bring strong medtech expertise and networks to guide SoNav toward clinical adoption in a neurosurgical device market environment projected to grow 4.5%–14.2% in the coming years.
The Medtech startup won Venture Kick in 2022. "Venture Kick was far more than initial funding – their early support and feedback laid the foundation for our growth and achievements, and set us on the path to today’s investor trust," highlighted Co-Founder Martin Hlavica.
rhovica Co-Founders Thomas Rhomberg and Martin Hlavica
EVD catheters are often placed blindly to relieve intracranial pressure after trauma or bleeding, posing clinical risks. SoNav provides real-time bedside visualization and guidance to improve accuracy, speed, and monitoring in intensive care.
To support its growth, Rhovica has appointed Carsten Laue, Managing Director at M2care, to its Board of Directors. Investors bring strong medtech expertise and networks to guide SoNav toward clinical adoption in a neurosurgical device market environment projected to grow 4.5%–14.2% in the coming years.
The Medtech startup won Venture Kick in 2022. "Venture Kick was far more than initial funding – their early support and feedback laid the foundation for our growth and achievements, and set us on the path to today’s investor trust," highlighted Co-Founder Martin Hlavica.
rhovica Co-Founders Thomas Rhomberg and Martin Hlavica